Skip to main content

Table 6 Multivariate analysis for predictors of distant recurrence based on the Cox proportional hazards regression model

From: Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer

Variables

Hazard ratio

95% Confidence interval

p value

11p15.5 loss

12.3

2.74–55.44

.001

Tumor size ≥ 2 cm

1.0

0.17–6.12

.965

Lymph node-positive

2.0

0.30–14.28

.457

Nuclear grade 3

3.3

0.40–28.19

.264

PR

1.5

0.38–6.46

.533

Age<35 years

0.9

0.87–1.04

.327